PACE GARY W — SEC Form 4 filings
SEC reporting owner CIK 1184778. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-08 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 1,368,900 shares, $2,687,299 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 119,323 shares, $3,656,226 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 90,000 shares @ $30.60 ($2,754,000) in Pacira BioSciences, Inc., filed 2024-03-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Director | 1 | — | 3 legs · 119,323 sh · $3,656,226 | — |
| Cardiff Oncology, Inc. (CRDF) | Director | 7 | 6 legs · 1,368,900 sh · $2,687,299 | — | 4 |
Form 4 filings — PACE GARY W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 687,285 @ $1.46 · Purchase (P): 687,285 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 30,000 @ $1.22 | EDGAR |
| 2026-06-15 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 40,565 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 275,000 @ $2.45 · Purchase (P): 15,000 @ $2.45 | EDGAR |
| 2025-06-27 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 40,565 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Cardiff Oncology, Inc. (CRDF) | Purchase (P): 350,115 @ $2.60 · Purchase (P): 11,500 @ $2.60 | EDGAR |
| 2024-07-01 | 4 | Cardiff Oncology, Inc. (CRDF) | Grant/award (A): 29,700 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 1,066 @ $29.67 · Sale (S): 28,257 @ $30.81 · Sale (S): 90,000 @ $30.60 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184778 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →